These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 2910699)

  • 1. [Elimination of aluminum via continuous ambulatory peritoneal dialysis].
    Passlick J; Wilhelm M; Busch T; Grabensee B; Ohnesorge FK
    Dtsch Med Wochenschr; 1989 Jan; 114(1):9-13. PubMed ID: 2910699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aluminum concentrations in serum, dialysate, urine and bone among patients undergoing continuous ambulatory peritoneal dialysis (CAPD).
    Joffe P; Olsen F; Heaf JG; Gammelgaard B; Pödenphant J
    Clin Nephrol; 1989 Sep; 32(3):133-8. PubMed ID: 2791364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aluminium in continuous ambulatory peritoneal dialysis and post dilutional hemofiltration.
    Mion C
    Clin Nephrol; 1985; 24 Suppl 1():S88-93. PubMed ID: 3915962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elimination of absorbed aluminum in patients undergoing continuous ambulatory peritoneal dialysis.
    Wilhelm M; Passlick J; Busch T; Ohnesorge FK
    J Toxicol Clin Toxicol; 1988; 26(3-4):209-21. PubMed ID: 3418776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clearance of osteocalcin in adults with end-stage renal disease undergoing CAPD.
    Klein JR; Grunewald RW; Steffgen J; Franz HE
    Adv Perit Dial; 1991; 7():225-9. PubMed ID: 1680431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calcium alginate, an aluminum-free phosphate binder, in patients on CAPD.
    Passlick J; Wilhelm M; Busch T; Grabensee B; Ohnesorge FK
    Clin Nephrol; 1989 Aug; 32(2):96-100. PubMed ID: 2766587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors influencing serum aluminum in CAPD patients.
    Montenegro J; Aguirre R; Saracho R; Moina I; Martínez I
    Clin Nephrol; 1998 Aug; 50(2):77-83. PubMed ID: 9725777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The alteration of dialysate cancer antigen 125 concentration under a biocompatible bicarbonate peritoneal dialysis solution and the preservation of the mesothelial cell viability.
    Theodoridis M; Passadakis P; Kriki P; Gioka T; Panagoutsos S; Mourvati E; Thodis E; Kantartzi K; Vargemezis V
    Ren Fail; 2008; 30(2):161-7. PubMed ID: 18300115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Accumulation of aluminum in the dialyzed patient: incidence, causes and possibilities of prevention].
    Sulková S; Laurincová Z; Lapcík O; Dlhopolcek P; Stodolová E; Komonová D
    Cas Lek Cesk; 1989 Jan; 128(1):16-9. PubMed ID: 2713883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Chronic aluminum poisoning in continuous ambulatory peritoneal dialysis: treatment with deferoxamine].
    Passlick J; Wilhelm M; Busch T; Grabensee B; Ohnesorge FK
    Dtsch Med Wochenschr; 1989 Feb; 114(7):253-7. PubMed ID: 2917487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The nutritional/metabolic and hormonal effects of 8 weeks of continuous ambulatory peritoneal dialysis with a 1% amino acid solution.
    Arfeen S; Goodship TH; Kirkwood A; Ward MK
    Clin Nephrol; 1990 Apr; 33(4):192-99. PubMed ID: 2190721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peritoneal transport status influence on atherosclerosis/inflammation in CAPD patients.
    Sezer S; Tutal E; Arat Z; Akçay A; Celik H; Ozdemir FN; Haberal M
    J Ren Nutr; 2005 Oct; 15(4):427-34. PubMed ID: 16198934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of radio contrast media on residual renal function in peritoneal dialysis patients--a prospective study.
    Dittrich E; Puttinger H; Schillinger M; Lang I; Stefenelli T; Hörl WH; Vychytil A
    Nephrol Dial Transplant; 2006 May; 21(5):1334-9. PubMed ID: 16046499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Benefits of biocompatible PD fluid for preservation of residual renal function in incident CAPD patients: a 1-year study.
    Kim S; Oh J; Kim S; Chung W; Ahn C; Kim SG; Oh KH
    Nephrol Dial Transplant; 2009 Sep; 24(9):2899-908. PubMed ID: 19258384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Influencing factors in the control of phosphorus in peritoneal dialysis. Therapeutic options].
    Gallar P; Ortega O; Gutiérrez M; Muñoz M; Hilara L; Oliet A; Rodríguez I; Giménez E; Vigil A
    Nefrologia; 2000; 20(4):355-61. PubMed ID: 11039261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The requirement of low calcium dialysate in patients on continuous ambulatory peritoneal dialysis receiving calcium carbonate as a phosphate binder.
    Cheng IK; Lu HB; Chan CY; Cheng SW; Robinson JD; Tam SC; Lo WK; Cheung WC
    Clin Nephrol; 1993 Aug; 40(2):100-5. PubMed ID: 8222365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aluminum hydroxide, calcium carbonate and calcium acetate in chronic intermittent hemodialysis patients.
    Janssen MJ; van der Kuy A; ter Wee PM; van Boven WP
    Clin Nephrol; 1996 Feb; 45(2):111-9. PubMed ID: 8846523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of intravenous and intraperitoneal fosfomycin in continuous ambulatory peritoneal dialysis.
    Bouchet JL; Albin H; Quentin C; de Barbeyrac B; Vinçon G; Martin-Dupont P; Potaux L; Aparicio M
    Clin Nephrol; 1988 Jan; 29(1):35-40. PubMed ID: 3383462
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies of aluminium mobilization in renal dialysis patients using the oral chelator 1,2-dimethyl-3-hydroxypyrid-4-one.
    Kontoghiorghes GJ; Barr J; Baillod RA
    Arzneimittelforschung; 1994 Apr; 44(4):522-6. PubMed ID: 8011008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.